| Market Cap | ₹14,063.6 CrSugar Sector |
|---|---|
| PE Ratio | 37.9Sector PE: 27.89 |
| 1-Year Return | 43.91%Price Performance |
| RSI | 49.04Neutral Zone |
| Metric | Q2-27 | Q1-27 | Q2-26 |
|---|---|---|---|
| Revenue from Operations | 1,876 | 1,637 | 1,671 |
| Other Income | 33.6 | 14.9 | 8.7 |
| Total Income | 1,910 | 1,652 | 1,680 |
| Profit Before Tax | 152 | 58.5 | 79.9 |
| Net Profit | 102 | 44.1 | 53.9 |
| Operating Margin | 7.9% | 3.5% | 4.8% |
| Net Profit QoQ | +132.0% | ||
| Net Profit YoY | +89.8% | ||
| Adj. Profit QoQ | +170.6% | ||
| Adj. Profit YoY | +65.7% | ||
Key highlights
- Net profit for Q2 FY27 jumped 89.8% YoY to ₹102 crore compared to ₹53.9 crore in the year-ago period
- Revenue from operations increased to ₹1,876 crore, representing an 12.3% growth over Q2 FY26
- Board declared an interim dividend of 400% amounting to ₹4.00 per equity share of ₹1 face value
- Operating margins expanded to 7.9% in Q2 FY27 from 4.8% in the same quarter last year
- The company raised ₹450 crore during the first half of the year through a preferential allotment of equity shares
- Sugar segment revenue stood at ₹1,578.05 crore, while the distillery segment contributed ₹324.59 crore
Strong Bottom-Line Growth and Margin Expansion
Balrampur Chini Mills demonstrated robust financial health in Q2 FY27, recording a net profit of ₹102 crore, a sharp 132% increase sequentially from ₹44.1 crore in Q1 FY27. This growth was underpinned by a steady rise in revenue from operations, which reached ₹1,876 crore. The company's operating margin saw a significant recovery, climbing to 7.9% from 4.8% in the corresponding quarter of the previous year.
While the sugar segment remains the primary revenue driver, contributing ₹1,578 crore, the distillery segment added ₹324.6 crore to the topline. Profit before tax for the quarter was reported at ₹152 crore, reflecting improved operational efficiencies and higher other income, which rose to ₹33.6 crore from ₹8.7 crore YoY.
Capital Infusion and Bioplastics Strategic Update
- Allotted 93,16,771 equity shares on a preferential basis at ₹483 per share to raise ₹450 crore
- Utilised ₹321.36 crore of the issue proceeds towards intended corporate objects by September 30, 2026
- Maintained ₹128.64 crore of unutilised issue proceeds in bank deposits and money market funds
- Continued development of the 80,000 TPA Polylactic Acid (PLA) bioplastics plant in Kumbhi, Uttar Pradesh
- Reported a segment loss of ₹558.27 lakhs in the nascent Polylactic Acid (PLA) division during the quarter
- Total revised project capex for the PLA facility stands at ₹3,080 crore with heavy investment in progress
Interim Dividend Declaration for FY 2026-27
Declared an Interim Dividend of 400% i.e. ₹4.00/- per equity share of ₹1/- each fully paid up for the Financial Year 2026-27 and the same shall be paid to the Equity Shareholders... as on Wednesday, 11th November, 2026 which is the Record Date fixed for the said purpose.
Governance and Management Reconstitution
Concurrent with the results, the company announced a reconstitution of its Board Committees effective November 4, 2026. Dr. Indu Bhushan, a Lead Independent Director, has been appointed as the Chairperson of the Audit Committee.
The Nomination and Remuneration Committee is now chaired by Ms. Veena Hingarh, while Mr. Chandra Kishore Mishra takes the lead for the Risk Management Committee.
These changes aim to strengthen the oversight as the company moves into its next phase of growth, particularly with the upcoming commercial commissioning of its greenfield bioplastics plant. The Board meeting commenced at 1:00 PM and concluded at 2:30 PM, signifying a focused review of the half-yearly progress.
| Date | Announcement | Amount |
|---|---|---|
| 11 Aug 2026 | Q1 FY27 consolidated net profitSource: chinimandi.com | ₹44.15 Cr |
| 15 May 2026 | Q4 FY26 consolidated net profitSource: money.rediff.com | ₹159.56 Cr |
| 10 Feb 2026 | Q3 FY26 consolidated net profitSource: multibagg.ai | ₹113.43 Cr |
| 11 Nov 2025 | Q2 FY26 consolidated net profitSource: multibagg.ai | ₹53.90 Cr |
| 12 Aug 2025 | Q1 FY26 consolidated net profitSource: upstox.com | ₹51.57 Cr |
| 15 May 2025 | Q4 FY25 consolidated net profitSource: business-standard.com | ₹229.12 Cr |
What to watch next
- Interim dividend record date on November 11, 2026
- Dividend payment to shareholders scheduled from November 26, 2026
- Commercial commissioning of the 80,000 TPA PLA plant in Kumbhi expected by December 2026
- Monitoring sugar segment performance during the upcoming seasonal crushing peak
| Share price | ₹664.5 |
|---|---|
| Market capitalisation | ₹14,063.60 Cr |
| Revenue (annual) | ₹6,271.15 Cr |
| Net profit (annual) | ₹378.46 Cr |
| Revenue (latest quarter) | ₹1,636.79 Cr+2.05% vs previous quarter |
| Net profit (latest quarter) | ₹44.15 Cr-72.33% vs previous quarter |
| P/E (TTM) | 37.9×Sector 27.89× |
| Promoter holding | 42.79%-0.07% QoQ |
| FII holding | 8.96%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Balrampur Chini Mills Limited announcing the outcome of the Board Meeting held on November 4, 2026, including Q2 FY27 results and interim dividend declaration. Market figures from a third-party data provider.
